UNSPSC 51172017: Oxazorone

This classification denotes a cholagogue/choleretic agent with the molecular formula C14H15NO4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 77243B845F. European Medicines Agency schedules oxazorone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09509MIG. The term OXAZORONE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 25, no. 10 1971, list 11. ).

OXAZORONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule oxazorone under HS 29349990 and SITC 51579. As of Q4 2014, OXAZORONE remains the US FDA Preferred Term for this commodity. Oxazorone bears US NLM identifiers UMLS ID C2825424 and NCI Concept Code C81043. SMILES: O1CCN(CC1)CC1C2C(OC(=O)C1)CC(O)CC2.

UNSPSC 51172017 Oxazorone, a Commodity code, addresses chemical testing supplies and reagents used in forensic and clinical laboratory work, though recent state and local procurement under this code focuses narrowly on drug-testing services rather than the chemical product itself. The scope of work solicited by state and local buyers centers on offender drug-testing operations, encompassing specimen collection, immunoassay screening, confirmatory analysis via LC/MS/MS or GC/MS, and alternative testing methodologies including oral fluid and hair analysis. Issuing bodies are primarily county criminal justice departments and community supervision agencies managing probation and pretrial populations. Lab certification requirements from SAMHSA, Texas DPS, or CAP indicate that vendors must meet rigorous compliance standards. Pricing models operate on a per-test basis with three service tiers—screening only, confirmation after screening, and screening with automatic confirmation of positives—and vendors must absorb all freight, delivery, insurance, and staffing costs with no pass-through surcharges permitted.

Collin County Community Supervision and Corrections Department in Texas is the primary recent buyer under this code, issuing RFP 2026-327 in September 2026 for Offender Specimen Collection and Drug Testing Services with a response deadline of July 23, 2026 and an estimated contract value of $600,000 over two years with three optional one-year renewals. The county's procurement calls for staffing two collection sites in Plano and McKinney, processing approximately 25,031 annual tests across five-panel and six-panel screens with ancillary testing, and maintaining an Interactive Voice Response system for randomized testing notifications. The evaluation criteria weight vendor understanding and qualifications at 55 points combined, cost at 30 points, and client references at 15 points, with optional Phase 2 demonstrations and interviews adding up to 30 additional points. Funding flows from Texas Department of Criminal Justice-Community Justice Assistance Division appropriations. This code shows limited recent activity; the single posted opportunity represents the primary market signal for state and local procurement under this Commodity designation.